| Sep'17 | Sep'16 | Sep'15 | Sep'14 | |||
|---|---|---|---|---|---|---|
Revenues: | ||||||
Product revenues | ||||||
22,356 | 25,362 | 26,514 | 32,202 | |||
Contract research and development revenues | ||||||
8,440 | 5,420 | 12,721 | 9,026 | |||
Other revenues | ||||||
1,068 | 2,241 | 1,686 | 1,212 | |||
Total revenues | ||||||
31,864 | 33,023 | 40,921 | 42,440 | |||
Costs and operating expenses: | ||||||
Cost of product revenues | ||||||
15,015 | 17,346 | 17,608 | 20,204 | |||
Cost of contract research and development revenues | ||||||
10,867 | 10,674 | 16,064 | 15,391 | |||
Research and development expenses | ||||||
31,884 | 21,687 | 16,454 | 7,365 | |||
General and administrative expenses | ||||||
13,163 | 11,566 | 11,185 | 9,095 | |||
Amortization of intangible assets | ||||||
690 | 659 | 622 | 547 | |||
Loss on disposal of equipment | ||||||
-6 | -15 | -12 | 112 | |||
Total costs and operating expenses | ||||||
71,625 | 61,947 | 61,945 | 52,490 | |||
Loss from operations | ||||||
-39,761 | -28,924 | -21,024 | -10,050 | |||
Interest income | ||||||
278 | 171 | 23 | 7 | |||
Interest expense | ||||||
8,303 | 7,947 | 7,446 | 6,961 | |||
Change in fair value of preferred stock warrant liability | ||||||
- | - | - | 274 | |||
Change in fair value of subordinated note embedded derivative liability | ||||||
- | - | - | 7,367 | |||
Loss before income taxes | ||||||
-47,786 | -36,700 | -28,447 | -9,911 | |||
Income tax expense | ||||||
7 | 3 | 3 | 1 | |||
Net loss and comprehensive loss | ||||||
-47,793 | -36,703 | -28,450 | -9,912 | |||
Net loss per share attributable to common stockholders, basic and diluted (in dollars per share) | ||||||
-1.64 | -1.65 | -1.52 | -0.99 | |||
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted (in shares) | ||||||
29,070 | 22,282 | 18,709 | 10,043 | |||